Publications Database

Aman M. G. et al. (2014)

A review of atomoxetine effects in young people with developmental disabilities.

Research in Developmental Disabilities

June, 35(6), pp. 1412-1424.

Read Full (New Window)

Arnold L. E. et al.

A 1.5-year follow-up of parent training and atomoxetine for attention-deficit hyperactivity disorder symptoms and noncompliant-disruptive behavior in autism.

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Arnold G. et al. (2003)

Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Journal of Autism and Developmental Disorders

33(4), pp. 449-454

Read Abstract (New Window)

Buie T. et al. (2010)

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.

Pediatrics

January, 125 S 1-18

Read Abstract (New Window) Read Full (New Window)

Gotham K. et al. (2008)

A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms.

Journal of the American Academy of Child and Adolescent Psychiatry

47(6), pp. 642-651

Read Abstract (New Window)

Handen B. L. et al. (2015)

Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 54(11), pp. 905-915.

Read Abstract (New Window)

Hyman S. L. , Levy S. E. (2005)

Introduction: novel therapies in developmental disabilities - hope, reason, and evidence.

Mental Retardation and Developmental Disabilities Research Reviews

11(2), pp. 107-109

Read Abstract (New Window)

Hyman S. L. et al. (2016)

The gluten-free, casein-free diet: a double-blind challenge trial in children with autism.

Journal of Autism and Developmental Disorders

January, 46(1), pp. 205-220.

Read Abstract (New Window)

Levy S. E. , Hyman S. L. (2008)

Complementary and alternative medicine treatments for children with autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 803-820

Read Abstract (New Window) Read Full (New Window)

Levy S. E. , Hyman S. L. (2005)

Novel treatments for autistic spectrum disorders.

Mental Retardation and Developmental Disabilities Research Reviews

11(2), pp. 131-142

Read Abstract (New Window)

Levy S. E. , Hyman S. L. (2003)

Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing.

Pediatric Annals

32(10), pp. 685-691

Read Abstract (New Window)

Malone R. P. et al. (2007)

Ziprasidone in adolescents with autism: an open-label pilot study.

Journal of Child and Adolescent Psychopharmacology

17(6), pp. 779-790

Read Abstract (New Window)

Perrin J. M. et al. (2012)

Complementary and alternative medicine use in a large pediatric autism sample.

Pediatrics

130 S77-82.

Read Abstract (New Window) Read Full (New Window)

Smith T. et al. (2016)

Atomoxetine and parent training for children with autism and attention-deficit-hyperactivity disorder: A 24-week extension study.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

October, 55(10),

Read Abstract (New Window)

Stewart P. A. et al. (2015)

Dietary supplementation in children with autism spectrum disorders: Common, insufficient, and excessive.

Journal of the Academy of Nutrition and Dietetics

Read Abstract (New Window)